Clinical lasting response of crizotinib in ALK positive lung squamous cell carcinoma with brain metastasis. (2017). European Journal of Oncology and Environmental Health, 22(2), 95-97. https://www.mattioli1885journals.com/index.php/EJOEH/article/view/4800